Metraipolis › archive › dc_ada4f52d79ff

Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses — Europe PMC PMID:41031196

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41031196
DOI: 10.3389/fneur.2025.1659670
License (as archived): solo-consultazione
Archived: 2026-11-09T22:57:19.605Z
SHA-256 of the archived text: 0e85d058d08204aa12e2c8c284aa615a34013608308207872c532e1d7af158fc
Stable URL of this page: https://metraipolis.com/documento/dc_ada4f52d79ff

How to cite

Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses — Europe PMC PMID:41031196 — Europe PMC (en), https://europepmc.org/article/MED/41031196 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ada4f52d79ff (Metraipolis archive dc_ada4f52d79ff, sha256 0e85d058d08204aa12e2c8c284aa615a34013608308207872c532e1d7af158fc)

BibTeX

@misc{dcada4f52d79ff,
  title = {Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses — Europe PMC PMID:41031196},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41031196},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ada4f52d79ff; sha256 0e85d058d08204aa12e2c8c284aa615a34013608308207872c532e1d7af158fc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41031196. Agents can read the archived copy with the MCP tool read_document.